Lack of Increased Risk of Lymphoma with Thiopurine Therapy Regardless of Dose and Duration of Treatment in Japanese Patients with Inflammatory Bowel Diseases

Conclusion: Dose or duration of thiopurine treatment did not explain a lack of increased risk of NHL with thiopurine use in Japanese patients with IBDs.Digestion

https://www.karger.com/Article/FullText/519560

Source: Digestion - January 4, 2022 Category: Gastroenterology Source Type: research